100 related articles for article (PubMed ID: 18787853)
1. [Stem cell-based in vitro models as alternative methods for toxicity and efficacy tests in animals].
Klemm M; Groebe K; Soskić V; Schrattenholz A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Sep; 51(9):1033-8. PubMed ID: 18787853
[TBL] [Abstract][Full Text] [Related]
2. Neuronal cell culture from human embryonic stem cells as in vitro model for neuroprotection.
Schrattenholz A; Klemm M
ALTEX; 2007; 24(1):9-15. PubMed ID: 17361316
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity of active compounds--establishment of hESC-lines and proteomics technologies for human embryo- and neurotoxicity screening and biomarker identification.
Klemm M; Schrattenholz A
ALTEX; 2004; 21 Suppl 3():41-8. PubMed ID: 15057407
[TBL] [Abstract][Full Text] [Related]
4. [Yes to research, no to utilization? Medical, pharmacological and toxicological utilization of human embryonic stem cells from an ethical point of view].
Kress H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Sep; 51(9):965-72. PubMed ID: 18773176
[TBL] [Abstract][Full Text] [Related]
5. Protein biomarkers for in vitro testing of embryotoxicity.
Groebe K; Hayess K; Klemm-Manns M; Schwall G; Wozny W; Steemans M; Peters AK; Sastri C; Jaeckel P; Stegmann W; Zengerling H; Schopf R; Poznanovic S; Stummann TC; Seiler A; Spielmann H; Schrattenholz A
J Proteome Res; 2010 Nov; 9(11):5727-38. PubMed ID: 20919680
[TBL] [Abstract][Full Text] [Related]
6. The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy.
Leist M; Bremer S; Brundin P; Hescheler J; Kirkeby A; Krause KH; Poerzgen P; Puceat M; Schmidt M; Schrattenholz A; Zak NB; Hentze H
ALTEX; 2008; 25(3):163-90. PubMed ID: 18841314
[TBL] [Abstract][Full Text] [Related]
7. The embryonic stem cell test for the early selection of pharmaceutical compounds.
Whitlow S; Bürgin H; Clemann N
ALTEX; 2007; 24(1):3-7. PubMed ID: 17361315
[TBL] [Abstract][Full Text] [Related]
8. Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure.
Colleoni S; Galli C; Gaspar JA; Meganathan K; Jagtap S; Hescheler J; Sachinidis A; Lazzari G
Toxicol Sci; 2011 Dec; 124(2):370-7. PubMed ID: 21934132
[TBL] [Abstract][Full Text] [Related]
9. An integrated approach for detecting embryotoxicity and developmental toxicity of environmental contaminants using in vitro alternative methods.
Sogorb MA; Pamies D; de Lapuente J; Estevan C; Estévez J; Vilanova E
Toxicol Lett; 2014 Oct; 230(2):356-67. PubMed ID: 24503011
[TBL] [Abstract][Full Text] [Related]
10. Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity.
Osman AM; van Dartel DA; Zwart E; Blokland M; Pennings JL; Piersma AH
Reprod Toxicol; 2010 Sep; 30(2):322-32. PubMed ID: 20553848
[TBL] [Abstract][Full Text] [Related]
11. Embryonic stem cell test: stem cell use in predicting developmental cardiotoxicity and osteotoxicity.
Kuske B; Pulyanina PY; zur Nieden NI
Methods Mol Biol; 2012; 889():147-79. PubMed ID: 22669664
[TBL] [Abstract][Full Text] [Related]
12. Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.
Pal R; Mamidi MK; Das AK; Bhonde R
J Cell Physiol; 2011 Jun; 226(6):1583-95. PubMed ID: 20945368
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of embryonic stem cell for evaluation of development neurotoxicity and test the validation of embryonic stem cell].
Yu Z; Xu H
Wei Sheng Yan Jiu; 2010 Nov; 39(6):685-8. PubMed ID: 21351631
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures.
van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
Toxicol Sci; 2011 Jan; 119(1):126-34. PubMed ID: 20935163
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylmercury exposure on neuronal differentiation of mouse and human embryonic stem cells.
He X; Imanishi S; Sone H; Nagano R; Qin XY; Yoshinaga J; Akanuma H; Yamane J; Fujibuchi W; Ohsako S
Toxicol Lett; 2012 Jul; 212(1):1-10. PubMed ID: 22555245
[TBL] [Abstract][Full Text] [Related]
16. Assaying embryotoxicity in the test tube: current limitations of the embryonic stem cell test (EST) challenging its applicability domain.
Riebeling C; Hayess K; Peters AK; Steemans M; Spielmann H; Luch A; Seiler AE
Crit Rev Toxicol; 2012 May; 42(5):443-64. PubMed ID: 22512667
[TBL] [Abstract][Full Text] [Related]
17. Individual and combined developmental toxicity assessment of bisphenol A and genistein using the embryonic stem cell test in vitro.
Kong D; Xing L; Liu R; Jiang J; Wang W; Shang L; Wei X; Hao W
Food Chem Toxicol; 2013 Oct; 60():497-505. PubMed ID: 23948354
[TBL] [Abstract][Full Text] [Related]
18. [Human embryonic stem cells. Perspectives for the study and therapy of neurological disorders].
Nolden L; Brüstle O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Sep; 51(9):1026-32. PubMed ID: 18773170
[TBL] [Abstract][Full Text] [Related]
19. Time-response evaluation by transcriptomics of methylmercury effects on neural differentiation of murine embryonic stem cells.
Theunissen PT; Pennings JL; Robinson JF; Claessen SM; Kleinjans JC; Piersma AH
Toxicol Sci; 2011 Aug; 122(2):437-47. PubMed ID: 21613230
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cells as a model for embryotoxicity screening.
Krtolica A; Ilic D; Genbacev O; Miller RK
Regen Med; 2009 May; 4(3):449-59. PubMed ID: 19438319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
